Sign In   |   Register
News
Filter news by category:

Recent events, essential information and the latest EAS news.

Displaying page 1 of 3
1  |  2  |  3

Publications
Tuesday 11 June 2019   (0 Comments - view/add)
Journal Highlights May - studies on atherosclerosis »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Tuesday 7 May 2019   (0 Comments - view/add)
Journal highlights March/April on state of the art of HDL in the management of ASCVD »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Friday 26 April 2019   (0 Comments - view/add)
Commentary: Novel therapeutics specific to lipoprotein(a) »
Novel therapeutics specific to lipoprotein(a) are now available and offer the means to test the ‘lipoprotein(a) hypothesis...
Monday 25 March 2019   (0 Comments - view/add)
Journal highlights on developments in gene regulation »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Friday 22 March 2019   (0 Comments - view/add)
Try Rapid Communications - Atherosclerosis journal »
If your high-quality article has received a rejection from a top-tier journal, consider submission to Atherosclerosis as a...
Friday 8 March 2019   (0 Comments - view/add)
Journal highlights on history & development of atherosclerotic diseases »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Thursday 21 February 2019   (0 Comments - view/add)
Commentary: Triglycerides and cardiovascular risk: apolipoprotein B holds the key »
In a recent Mendelian randomization study, the clinical benefit from treatments that lower LDL cholesterol or triglyceride...
Thursday 31 January 2019   (0 Comments - view/add)
Journal highlights December on clinical risk predictions »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Tuesday 15 January 2019   (0 Comments - view/add)
Your feedback important - joint ESC/EAS survey on current beliefs and practices in lipid management »
The joint ESC/EAS task force needs your input concerning your views and practice patterns regarding lipid management....
Monday 14 January 2019   (0 Comments - view/add)
A look back at 2018: What made the news? A featured Commentary by Jane K. Stock »
This new commentary, by EAS Scientific writer Jane K. Stock, discusses highlights from clinical trials reporting in 2018;...
Monday 7 January 2019   (0 Comments - view/add)
EAS announces Atherosclerosis: X - the open access mirror journal of Atherosclerosis »
We are glad to announce the release of a fully open access mirror journal of Atherosclerosis named Atherosclerosis: X ....
Thursday 20 December 2018   (0 Comments - view/add)
Journal highlights November on ASCVD in children and adolescents »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Thursday 29 November 2018   (0 Comments - view/add)
Commentary on Lipid guidelines in the USA and Europe: A meeeting of the minds? »
After a five year wait, the American College of Cardiology and American Heart Association published new guidelines for the...
Thursday 22 November 2018   (0 Comments - view/add)
Journal highlights October on Global care of FH, measurement of LDL cholesterol and more FH articles »
In our regular feature, Editor-in-Chief Arnold von Eckardstein and Simona Negrini highlight interesting articles from rece...
Friday 19 October 2018   (0 Comments - view/add)
Journal highlights September on inflammation and its interaction with lipoproteins »
In addition to lipid accumulation, inflammation is a hallmark of atherosclerotic lesions. The present issue of Atheroscler...
Thursday 27 September 2018   (0 Comments - view/add)
Commentary September: Cholesterol & inflammatory risk: insights from secondary & primary prevention »
Low-density lipoprotein cholesterol is indisputably causal for cardiovascular disease, and a major modifiable risk factor....
Monday 17 September 2018   (0 Comments - view/add)
Journal highlights August on lifestyle, obesity, insulin sensitivity, diabetes, non-alcoholic ... »
This issue of Atherosclerosis contains several articles describing the interactions of lifestyle, obesity, insulin sensiti...
Thursday 13 September 2018   (0 Comments - view/add)
Commentary August: Optimal cardiovascular health: also good for the brain »
Optimal cardiovascular health from an early age has a beneficial impact on long-term cardiometabolic risk, conferring gain...
Tuesday 14 August 2018   (0 Comments - view/add)
Journal hightlights July on lifestyle factors and cardiovascular risk »
Volume 274 Issue July 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . This issue...
Monday 6 August 2018   (0 Comments - view/add)
New Joint Consensus Initiative on Quantifying Atherogenic Lipoproteins »
The last decade has seen a revolution in the management of low-density lipoprotein cholesterol (LDL-C), the guideline-reco...
Tuesday 10 July 2018   (0 Comments - view/add)
Journal highlights June - HDL and Valve disease »
Volume 273 Issue June 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . High-densit...
Thursday 31 May 2018   (0 Comments - view/add)
Society journal news: Rapid Communication »
Atherosclerosis journal - Rapid Communications If your high-quality article has received a rejection from a to...
Tuesday 29 May 2018   (0 Comments - view/add)
Journal highlights May - Hypertriglyceridemia, hyperglycemia and hyperuricemia »
Volume 272 Issue May 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . Hypertriglyc...
Thursday 24 May 2018   (0 Comments - view/add)
Editorial "Highlights of EAS Congress Lisbon" »
As ever, the European Atherosclerosis Society (EAS) Congress delivered on its promise for news in atherosclerosis and card...
Friday 4 May 2018   (0 Comments - view/add)
Journal Highlights April - atherosclerotic cardiovascular diseases (ASCVD) risk »
Volume 271 Issue April 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . Diabetes...
Thursday 3 May 2018
SAMS & Statins - new Clinicians handbook app now available »
New Clinicians hanbook app, now available to download Statin-Associated Muscle Symptoms (SAMS): Definition, Assess...
Friday 27 April 2018   (0 Comments - view/add)
New EAS Consensus Panel Statement addresses persistent questions on long-term statin safety »
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase [HMG-CoA] inhibitors) are recommended by guidelines as first-line...
Monday 9 April 2018   (0 Comments - view/add)
Editorial "At the end of the ODYSSEY…what now for PCSK9 inhibition in practice?" »
In March, the second of the cardiovascular outcomes studies with a PCSK9 inhibitor reported, showing significant clinical...
Tuesday 27 March 2018   (0 Comments - view/add)
Journal Highlights March - Atherosclerotic cardiovascular disease (ASCVD) »
Volume 270 Issue March 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . Atheroscler...
Tuesday 27 February 2018   (0 Comments - view/add)
Journal Highlights February - technology in molecular genetics »
Volume 269 Issue February 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . This iss...
Thursday 8 February 2018   (0 Comments - view/add)
New editorial on the highs and lows of cardiovascular disease prevention »
In 2017, three major trials provided important insights into cardiovascular disease prevention. The first of these, FOURIE...
Thursday 1 February 2018   (0 Comments - view/add)
Journal Highlights January - presence or severity of ASCVD with imaging »
Volume 268 Issue January 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . The succe...
Thursday 21 December 2017   (0 Comments - view/add)
Journal highlights December - novel advances in the research on inflammation in atherosclerosis »
Volume 267 Issue December 2017 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . From th...
Thursday 7 December 2017   (0 Comments - view/add)
New editorial on Peripheral arterial disease (PAD) »
The challenge of peripheral arterial disease: how do we improve outcome? Lower extremity peripheral arterial disease (P...
Tuesday 28 November 2017   (0 Comments - view/add)
Atherosclerosis journal highlights November issue 2017 »
Volume 266 Issue November 2017 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . Associa...

Displaying page 1 of 3
1  |  2  |  3

Visiting Address
Mässans Gata 10, SE-412 51, Göteborg
Post to be addressed to
Box 5243, SE-402 24, Göteborg, SWEDEN

Organisation number: 802418-0427

Telephone
+46(0)31 760 24 27

Fax
+46(0)31 81 20 22

Email
office@eas-society.org

Foot Logo
 
©2018 European Atherosclerosis Society | EAS Data handling policy (GDPR)
Membership Software Powered by YourMembership  ::  Legal